|
AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement
AMAG Pharmaceuticals, Inc. and Endoceutics, Inc. announced that they have entered into an exclusive license agreement that provides AMAG with U.S....
|
|
ICON Selected by the FDA to validate Patient reported outcome endpoints for Antibacterial Drug Trials
ICON plc a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries.
|
|